docetaxel anhydrous has been researched along with carbocyanines in 5 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (carbocyanines) | Trials (carbocyanines) | Recent Studies (post-2010) (carbocyanines) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 5,287 | 4 | 2,147 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SH; Jeong, SY; Kim, K; Koo, AN; Kwon, IC; Lee, HJ; Lee, SC; Lee, SU; Min, KH | 1 |
| Jayakumar, R; Lakshmanan, VK; Maya, S; Menon, D; Sarmento, B | 1 |
| Abal, M; Abellan-Pose, R; Alonso, MJ; Alonso-Nocelo, M; Csaba, N; de la Fuente, M; Lopez-Lopez, R; Vidal, A | 1 |
| Cho, HJ; Kim, DD; Park, JH | 1 |
| Beloglazkina, EK; Garanina, AS; Grishin, YK; Machulkin, AE; Majouga, AG; Nimenko, EA; Petrov, RA; Petrov, SA; Polshakov, VI; Roznyatovsky, VA; Uspenskaya, AA; Zyk, NV; Zyk, NY | 1 |
5 other study(ies) available for docetaxel anhydrous and carbocyanines
| Article | Year |
|---|---|
Tumor accumulation and antitumor efficacy of docetaxel-loaded core-shell-corona micelles with shell-specific redox-responsive cross-links.
Topics: Animals; Antineoplastic Agents; Carbocyanines; Cell Line, Tumor; Cross-Linking Reagents; Diagnostic Imaging; Disulfides; Docetaxel; Humans; In Situ Nick-End Labeling; Mice; Micelles; Neoplasms; Oxidation-Reduction; Particle Size; Peptides; Polyethylene Glycols; Polylysine; Taxoids; Time Factors; Tissue Distribution; Treatment Outcome | 2012 |
Actively targeted cetuximab conjugated gamma-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cells.
Topics: Animals; Annexins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzimidazoles; Carbocyanines; Cell Cycle; Cell Death; Cetuximab; Colonic Neoplasms; Docetaxel; Drug Carriers; ErbB Receptors; Hemolysis; HT29 Cells; Humans; Mice; Nanomedicine; Nanoparticles; Polyglutamic Acid; Taxoids; Tissue Distribution | 2014 |
Selective interaction of PEGylated polyglutamic acid nanocapsules with cancer cells in a 3D model of a metastatic lymph node.
Topics: A549 Cells; Antineoplastic Agents; Carbocyanines; Cell Cycle; Coculture Techniques; Docetaxel; Fluorescent Dyes; Humans; Jurkat Cells; Lymph Nodes; Lymphatic Metastasis; Models, Biological; Nanocapsules; Particle Size; Polyethylene Glycols; Polyglutamic Acid; Rheology; Taxoids | 2016 |
Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.
Topics: Animals; Antineoplastic Agents; Carbocyanines; Cell Line; Docetaxel; Drug Delivery Systems; Drug Liberation; Glucose; Glucose Transport Proteins, Facilitative; Humans; Hypoglycemia; Lactic Acid; Mice; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2017 |
Polypeptide-Based Molecular Platform and Its Docetaxel/Sulfo-Cy5-Containing Conjugate for Targeted Delivery to Prostate Specific Membrane Antigen.
Topics: Amino Acid Sequence; Antigens, Surface; Carbocyanines; Chemistry Techniques, Synthetic; Docetaxel; Drug Carriers; Drug Delivery Systems; Glutamate Carboxypeptidase II; Molecular Structure; Peptides | 2020 |